RecruitingNot Applicable

Feminizing Treatment in Transgender Women and Non-binary Persons

Denmark100 participantsStarted 2022-02-01

Plain-language summary

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * assigned male at birth and eligeble for gender affirming feminizing treatment Exclusion Criteria: none \-

What they're measuring

coronary plaque formation

Timeframe: 1 year

Trial details

NCT IDNCT05169762

SponsorOdense University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2035-09-01

Contact for this trial

Dorte Glintborg

+4565411807 dorte.glintborg@rsyd.dk

View on ClinicalTrials.gov More Transgenderism trials